Literature DB >> 2982900

The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing's syndrome.

S Refetoff, E Van Cauter, V S Fang, C Laderman, M L Graybeal, R L Landau.   

Abstract

ACTH and cortisol are normally secreted episodically rather than continuously. This characteristic of episodic secretion is preserved in patients with Cushing's syndrome. To determine whether exogenous glucocorticoids modulate this pulsatility and to study its possible etiological implications, we obtained 24-h plasma cortisol profiles in seven patients with Cushing's syndrome (five Cushing's disease, one adrenal adenoma, and one bilateral adrenal cortical macronodular hyperplasia) before and during suppression with various doses of dexamethasone [low (0.5 mg, every 6 h), high (2 mg, every 6 h), and very high (4 mg, every 6 h)]. Simultaneous 24-h plasma ACTH profiles were obtained in two patients with Cushing's disease. Blood was drawn at 30-min intervals for 25 h. Individual profiles were analyzed to determine the 24-h mean level, the presence of a circadian component and its amplitude, and the number and magnitude of significant secretory pulses over the 24-h span. The concordance between significant ACTH and cortisol pulses also was quantified. Baseline values in patients were compared to those in seven normal subjects. Under basal conditions, the 24-h mean cortisol level was 3- to 4-fold higher than normal in all patients with Cushing's syndrome. In contrast, the basal 24-h mean ACTH level was normal in one, and slightly elevated in the other of the two patients with Cushing's disease in whom plasma ACTH concentrations were measured. However, in contrast to the normal subjects, all ACTH values were above 10 pg/ml even during the period of minimal secretion. Basal circadian variation in adrenocortical activity, albeit of reduced amplitude, was found in four of five patients with Cushing's disease; it was absent in the patient with adrenal adenoma. Low dose dexamethasone reduced the 24-h mean cortisol level and increased the amplitude of the circadian rhythm, unmasking a diurnal rhythm in the single patient with Cushing's disease in whom no significant circadian periodicity was present in the basal condition. This effect was further increased with the high dose of dexamethasone, which concomitantly reduced the number and increments of the secretory pulses. A lesser effect was found in the patient with bilateral nodular hyperplasia, and no effect was seen in the patient with adrenal adenoma. ACTH pulsatility, but not diurnal rhythm, also was dampened by dexamethasone. Reduction in the magnitude, but not the number, of ACTH secretory pulses by dexamethasone produced a reduced concordance ratio of ACTH with cortisol pulses of 0.39, compared to 0.64 in the basal state.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2982900     DOI: 10.1210/jcem-60-3-527

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

1.  Circadian variation in Cushing's disease and pseudo-Cushing states by analysis of F and ACTH pulsatility.

Authors:  J M Cunningham; O M Buxton; R E Weiss
Journal:  J Endocrinol Invest       Date:  2002-10       Impact factor: 4.256

2.  The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.

Authors:  Lynnette K Nieman; Beverly M K Biller; James W Findling; John Newell-Price; Martin O Savage; Paul M Stewart; Victor M Montori
Journal:  J Clin Endocrinol Metab       Date:  2008-03-11       Impact factor: 5.958

3.  Quantifying Pituitary-Adrenal Dynamics and Deconvolution of Concurrent Cortisol and Adrenocorticotropic Hormone Data by Compressed Sensing.

Authors:  Rose T Faghih; Munther A Dahleh; Gail K Adler; Elizabeth B Klerman; Emery N Brown
Journal:  IEEE Trans Biomed Eng       Date:  2015-04-29       Impact factor: 4.538

4.  Cushing's syndrome with intermittent ectopic ACTH production.

Authors:  A van Coevorden; E Laurent; F Rickaert; O van Reeth; E Van Cauter; J Mockel
Journal:  J Endocrinol Invest       Date:  1990-04       Impact factor: 4.256

5.  Consensus-driven in-hospital cortisol assessment after ACTH-secreting pituitary adenoma resection.

Authors:  Yana Stolyarov; James Mirocha; Adam N Mamelak; Anat Ben-Shlomo
Journal:  Pituitary       Date:  2018-02       Impact factor: 4.107

6.  Diurnal Plasma Cortisol Measurements Utility in Differentiating Various Etiologies of Endogenous Cushing Syndrome.

Authors:  A Tirosh; M B Lodish; G Z Papadakis; C Lyssikatos; E Belyavskaya; C A Stratakis
Journal:  Horm Metab Res       Date:  2016-09-19       Impact factor: 2.936

Review 7.  The diagnosis of Cushing's syndrome.

Authors:  Ty B Carroll; James W Findling
Journal:  Rev Endocr Metab Disord       Date:  2010-06       Impact factor: 6.514

8.  Intravenous dexamethasone and subsequent ACTH test in comparison with dexamethasone oral test in the diagnosis of Cushing's syndrome: a report of 20 cases.

Authors:  S Gambardella; G Tamburrano; A Giaccari; S Frontoni; A Lala; V Spallone; A Barini; M G Felici; G Menzinger
Journal:  J Endocrinol Invest       Date:  1989-03       Impact factor: 4.256

9.  Ketoconazole treatment in Cushing's disease. Effect on the circadian profile of plasma ACTH and cortisol.

Authors:  M Terzolo; M Panarelli; A Piovesan; M Torta; P Paccotti; A Angeli
Journal:  J Endocrinol Invest       Date:  1988-11       Impact factor: 4.256

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.